GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Shares Buyback Ratio %

ChemoMetec AS (FRA:CHY) Shares Buyback Ratio % : 0.00 (As of Jul. 23, 2025)


View and export this data going back to 2019. Start your Free Trial

What is ChemoMetec AS Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. ChemoMetec AS's current shares buyback ratio was 0.00%.

ChemoMetec AS Shares Buyback Ratio % Historical Data

The historical data trend for ChemoMetec AS's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Shares Buyback Ratio % Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.47 - - - -

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ChemoMetec AS Shares Buyback Ratio % Calculation

ChemoMetec AS's Shares Buyback Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Jun. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(17.402 - 17.402) / 17.402
=0.00%

ChemoMetec AS's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(17.402 - 17.402) / 17.402
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Shares Buyback Ratio %
Comparable Companies
OCSE:GN OCSE:EMBLA OCSE:SMSMED OCSE:VIRO OCSE:AMBU B ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE XAMS:PHIA PODD ZBH XSWX:SOON SHSE:688271 LSE:SN.
Traded in Other Exchanges
CHEMMc:UK 0DZ0:UK CHEMM:Denmark CHY:Germany
Address
Gydevang 43, Allerod, DNK, 3450
Website
https://www.chemometec.com
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.